Document is current

Article History

Received: 15 August 2023

Accepted: 7 March 2024

First Online: 13 March 2024

Declarations

:

: The research protocol was deemed IRB-exempt by Advarra Institutional Review Board, Protocol Pro00065596. The study was deemed exempt under the Department of Health and Human Services Regulations at 45 CFR 46.104(d)(2). All participants also provided informed consent to participate. Consent language can be reviewed in the submitted Appendix, which contains the full questionnaire.

: Not applicable.

: All authors are employees of Mirvie, Inc., the study's funder.